Autopsy report · NCT00269607

Naltrexone Implants as Relapse Prevention

“Recruitment difficulties. Reframed as pilot study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months after it had already started.
• Ran for about 1 year 7 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

University of Oslo

Sponsor type

University, hospital or other

Conditions

Opioid Dependency

Interventions

Implantation of naltrexone implants

Participants

12

Trials that died the same way

• Improving Access to Psychiatric Care for Patients in Primary Care
  “recruitment difficulties” (86% match in meaning)
• Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
  “Difficulties in recruitment” (85% match in meaning)
• Robotic Decompression of the Pudendal Nerve in Pudendal Neuralgia
  “recruitments difficulties” (85% match in meaning)
• Alzheimer Disease : Rehabilitation's Intervention at Home
  “difficulties of recruitment” (85% match in meaning)
• Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
  “Difficulty with recruitment.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.